Global Induced Pluripotent Stem Cells (iPSCs) Industry Growth and Trends Forecast to 2031

Summary

Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.

According to APO Research, The global Induced Pluripotent Stem Cells (iPSCs) market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global companies of Induced Pluripotent Stem Cells (iPSCs) include Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology and ReproCELL, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Induced Pluripotent Stem Cells (iPSCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Induced Pluripotent Stem Cells (iPSCs).

The Induced Pluripotent Stem Cells (iPSCs) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Induced Pluripotent Stem Cells (iPSCs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Induced Pluripotent Stem Cells (iPSCs) Segment by Company

Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL

Induced Pluripotent Stem Cells (iPSCs) Segment by Type

Human iPSCs
Mouse iPSCs

Induced Pluripotent Stem Cells (iPSCs) Segment by Application

Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others

Induced Pluripotent Stem Cells (iPSCs) Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Induced Pluripotent Stem Cells (iPSCs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Induced Pluripotent Stem Cells (iPSCs) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Induced Pluripotent Stem Cells (iPSCs).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Induced Pluripotent Stem Cells (iPSCs) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview

1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Overview by Region 2020 VS 2024 VS 2031
1.4 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2020-2031)
1.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2020-2025)
1.4.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2026-2031)
1.5 Key Regions Induced Pluripotent Stem Cells (iPSCs) Market Size (2020-2031)
1.5.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2020-2031)
1.5.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2020-2031)
1.5.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2020-2031)
1.5.4 South America Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2020-2031)
1.5.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2020-2031)
2 Induced Pluripotent Stem Cells (iPSCs) Market by Type

2.1 Type Introduction
2.1.1 Human iPSCs
2.1.2 Mouse iPSCs
2.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
2.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Overview by Type (2020-2031)
2.2.2 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size Review by Type (2020-2025)
2.2.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecasted by Type (2026-2031)
2.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions
2.3.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Type (2020-2025)
2.3.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Type (2020-2025)
2.3.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Type (2020-2025)
2.3.4 South America Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Type (2020-2025)
2.3.5 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Type (2020-2025)
3 Induced Pluripotent Stem Cells (iPSCs) Market by Application

3.1 Type Introduction
3.1.1 Academic Research
3.1.2 Drug Development and Discovery
3.1.3 Toxicity Screening
3.1.4 Regenerative Medicine
3.1.5 Others
3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
3.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Overview by Application (2020-2031)
3.2.2 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size Review by Application (2020-2025)
3.2.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecasted by Application (2026-2031)
3.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions
3.3.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Application (2020-2025)
3.3.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Application (2020-2025)
3.3.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Application (2020-2025)
3.3.4 South America Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Application (2020-2025)
3.3.5 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Application (2020-2025)
4 Global Market Dynamics

4.1 Induced Pluripotent Stem Cells (iPSCs) Industry Trends
4.2 Induced Pluripotent Stem Cells (iPSCs) Industry Drivers
4.3 Induced Pluripotent Stem Cells (iPSCs) Industry Opportunities and Challenges
4.4 Induced Pluripotent Stem Cells (iPSCs) Industry Restraints
5 Competitive Insights by Company

5.1 Global Top Players by Induced Pluripotent Stem Cells (iPSCs) Revenue (2020-2025)
5.2 Global Induced Pluripotent Stem Cells (iPSCs) Industry Company Ranking, 2023 VS 2024 VS 2025
5.3 Global Induced Pluripotent Stem Cells (iPSCs) Key Company Headquarters & Area Served
5.4 Global Induced Pluripotent Stem Cells (iPSCs) Company, Product Type & Application
5.5 Global Induced Pluripotent Stem Cells (iPSCs) Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Induced Pluripotent Stem Cells (iPSCs) Market CR5 and HHI
5.6.2 Global Top 5 and 10 Induced Pluripotent Stem Cells (iPSCs) Players Market Share by Revenue in 2024
5.6.3 2024 Induced Pluripotent Stem Cells (iPSCs) Tier 1, Tier 2, and Tier 3
6 Company Profiles

6.1 Fujifilm Holding Corporation (CDI)
6.1.1 Fujifilm Holding Corporation (CDI) Comapny Information
6.1.2 Fujifilm Holding Corporation (CDI) Business Overview
6.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue, Global Share and Gross Margin (2020-2025)
6.1.4 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
6.1.5 Fujifilm Holding Corporation (CDI) Recent Developments
6.2 Ncardia
6.2.1 Ncardia Comapny Information
6.2.2 Ncardia Business Overview
6.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue, Global Share and Gross Margin (2020-2025)
6.2.4 Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
6.2.5 Ncardia Recent Developments
6.3 Sumitomo Dainippon Pharma
6.3.1 Sumitomo Dainippon Pharma Comapny Information
6.3.2 Sumitomo Dainippon Pharma Business Overview
6.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue, Global Share and Gross Margin (2020-2025)
6.3.4 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
6.3.5 Sumitomo Dainippon Pharma Recent Developments
6.4 Astellas Pharma Inc
6.4.1 Astellas Pharma Inc Comapny Information
6.4.2 Astellas Pharma Inc Business Overview
6.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Global Share and Gross Margin (2020-2025)
6.4.4 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
6.4.5 Astellas Pharma Inc Recent Developments
6.5 Fate Therapeutics, Inc
6.5.1 Fate Therapeutics, Inc Comapny Information
6.5.2 Fate Therapeutics, Inc Business Overview
6.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Global Share and Gross Margin (2020-2025)
6.5.4 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
6.5.5 Fate Therapeutics, Inc Recent Developments
6.6 Pluricell Biotech
6.6.1 Pluricell Biotech Comapny Information
6.6.2 Pluricell Biotech Business Overview
6.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue, Global Share and Gross Margin (2020-2025)
6.6.4 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
6.6.5 Pluricell Biotech Recent Developments
6.7 Cell Inspire Biotechnology
6.7.1 Cell Inspire Biotechnology Comapny Information
6.7.2 Cell Inspire Biotechnology Business Overview
6.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue, Global Share and Gross Margin (2020-2025)
6.7.4 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
6.7.5 Cell Inspire Biotechnology Recent Developments
6.8 ReproCELL
6.8.1 ReproCELL Comapny Information
6.8.2 ReproCELL Business Overview
6.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue, Global Share and Gross Margin (2020-2025)
6.8.4 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
6.8.5 ReproCELL Recent Developments
7 North America

7.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025)
7.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2026-2031)
8 Europe

8.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025)
8.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2026-2031)
9 Asia-Pacific

9.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025)
9.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2026-2031)
10 South America

10.1 South America Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2 South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025)
10.3 South America Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2026-2031)
11 Middle East & Africa

11.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025)
11.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2026-2031)
12 Concluding Insights
13 Appendix

13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings